Proteomics in celiac disease

V. De Re, M. P. Simula, L. Caggiari, A. Pavan, V. Canzonieri, R. Cannizzaro

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Proteomic technologies are used with increasing frequency in the scientific community. In this review we would like to highlight their use in celiac disease. The available techniques that include two-dimensional gel electrophoresis, mass spectrometry, antibody and tissue arrays, have been used to identify proteins or protein expression changes specific of gut tissue from patients with celiac disease. A number of studies have employed proteomic methodologies to look for diagnostic biomarkers in body fluids or to examine protein expression changes and posttranslational modifications during signaling. The fast technological development of technologies, along with the combination of classic techniques with proteomics, will lead to new discoveries which will consent a better understanding of the pathogenesis of celiac disease and its complications (i.e. refractory CD and cancer), and to possibily indicate targets for an early diagnosis of CD complications and for specific terapeutic approaches.

Original languageEnglish
Title of host publicationProteomics: Methods, Applications and Limitations
PublisherNova Science Publishers, Inc.
Pages1-14
Number of pages14
ISBN (Print)9781616686918
Publication statusPublished - 2011

Fingerprint

Celiac Disease
Proteomics
Tissue
Technology
Proteins
Body fluids
Electrophoresis, Gel, Two-Dimensional
Body Fluids
Biomarkers
Post Translational Protein Processing
Electrophoresis
Refractory materials
Mass spectrometry
Early Diagnosis
Mass Spectrometry
Gels
Antibodies
Neoplasms

Keywords

  • Lymphomas.
  • MALDI-TOF
  • Mass spectrometry
  • T-cell lymphoproliferations
  • Two-dimensional gel electrophoresis: DIGE

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

De Re, V., Simula, M. P., Caggiari, L., Pavan, A., Canzonieri, V., & Cannizzaro, R. (2011). Proteomics in celiac disease. In Proteomics: Methods, Applications and Limitations (pp. 1-14). Nova Science Publishers, Inc..

Proteomics in celiac disease. / De Re, V.; Simula, M. P.; Caggiari, L.; Pavan, A.; Canzonieri, V.; Cannizzaro, R.

Proteomics: Methods, Applications and Limitations. Nova Science Publishers, Inc., 2011. p. 1-14.

Research output: Chapter in Book/Report/Conference proceedingChapter

De Re, V, Simula, MP, Caggiari, L, Pavan, A, Canzonieri, V & Cannizzaro, R 2011, Proteomics in celiac disease. in Proteomics: Methods, Applications and Limitations. Nova Science Publishers, Inc., pp. 1-14.
De Re V, Simula MP, Caggiari L, Pavan A, Canzonieri V, Cannizzaro R. Proteomics in celiac disease. In Proteomics: Methods, Applications and Limitations. Nova Science Publishers, Inc. 2011. p. 1-14
De Re, V. ; Simula, M. P. ; Caggiari, L. ; Pavan, A. ; Canzonieri, V. ; Cannizzaro, R. / Proteomics in celiac disease. Proteomics: Methods, Applications and Limitations. Nova Science Publishers, Inc., 2011. pp. 1-14
@inbook{efc351eea2a5406f957f3fcfcf880772,
title = "Proteomics in celiac disease",
abstract = "Proteomic technologies are used with increasing frequency in the scientific community. In this review we would like to highlight their use in celiac disease. The available techniques that include two-dimensional gel electrophoresis, mass spectrometry, antibody and tissue arrays, have been used to identify proteins or protein expression changes specific of gut tissue from patients with celiac disease. A number of studies have employed proteomic methodologies to look for diagnostic biomarkers in body fluids or to examine protein expression changes and posttranslational modifications during signaling. The fast technological development of technologies, along with the combination of classic techniques with proteomics, will lead to new discoveries which will consent a better understanding of the pathogenesis of celiac disease and its complications (i.e. refractory CD and cancer), and to possibily indicate targets for an early diagnosis of CD complications and for specific terapeutic approaches.",
keywords = "Lymphomas., MALDI-TOF, Mass spectrometry, T-cell lymphoproliferations, Two-dimensional gel electrophoresis: DIGE",
author = "{De Re}, V. and Simula, {M. P.} and L. Caggiari and A. Pavan and V. Canzonieri and R. Cannizzaro",
year = "2011",
language = "English",
isbn = "9781616686918",
pages = "1--14",
booktitle = "Proteomics: Methods, Applications and Limitations",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Proteomics in celiac disease

AU - De Re, V.

AU - Simula, M. P.

AU - Caggiari, L.

AU - Pavan, A.

AU - Canzonieri, V.

AU - Cannizzaro, R.

PY - 2011

Y1 - 2011

N2 - Proteomic technologies are used with increasing frequency in the scientific community. In this review we would like to highlight their use in celiac disease. The available techniques that include two-dimensional gel electrophoresis, mass spectrometry, antibody and tissue arrays, have been used to identify proteins or protein expression changes specific of gut tissue from patients with celiac disease. A number of studies have employed proteomic methodologies to look for diagnostic biomarkers in body fluids or to examine protein expression changes and posttranslational modifications during signaling. The fast technological development of technologies, along with the combination of classic techniques with proteomics, will lead to new discoveries which will consent a better understanding of the pathogenesis of celiac disease and its complications (i.e. refractory CD and cancer), and to possibily indicate targets for an early diagnosis of CD complications and for specific terapeutic approaches.

AB - Proteomic technologies are used with increasing frequency in the scientific community. In this review we would like to highlight their use in celiac disease. The available techniques that include two-dimensional gel electrophoresis, mass spectrometry, antibody and tissue arrays, have been used to identify proteins or protein expression changes specific of gut tissue from patients with celiac disease. A number of studies have employed proteomic methodologies to look for diagnostic biomarkers in body fluids or to examine protein expression changes and posttranslational modifications during signaling. The fast technological development of technologies, along with the combination of classic techniques with proteomics, will lead to new discoveries which will consent a better understanding of the pathogenesis of celiac disease and its complications (i.e. refractory CD and cancer), and to possibily indicate targets for an early diagnosis of CD complications and for specific terapeutic approaches.

KW - Lymphomas.

KW - MALDI-TOF

KW - Mass spectrometry

KW - T-cell lymphoproliferations

KW - Two-dimensional gel electrophoresis: DIGE

UR - http://www.scopus.com/inward/record.url?scp=84891998557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891998557&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84891998557

SN - 9781616686918

SP - 1

EP - 14

BT - Proteomics: Methods, Applications and Limitations

PB - Nova Science Publishers, Inc.

ER -